Algorithm That Predicts the Hematopoietic Stem Cell's Decision in Advance

Today, cell biology is no longer limited to static states but also attempts to understand the dynamic development of cell populations.

A hematopoietic stem cell's decision to become a certain cell type cannot be observed. At this time, it is only possible to verify the decision retrospectively with cell surface markers.

Researchers have now developed an algorithm that can predict the decision in advance.

Hematopoietic Stem Cells Regulate Their Own Proliferation
Hematopoietic stem cells give rise to all blood cells, and these cells self-renew by making copies of themselves, and at the same time generate blood cells.

‘The new algorithm classifies light microscopic images and videos of individual cells by comparing these data with past experience from the development of such cells. In this way, the algorithm 'learns' how certain cells behave.’

Dr. Carsten Marr, head of the Quantitative Single Cell Dynamics Research Group at the Helmholtz Zentrum München's Institute of Computational Biology (ICB), said, "Deep Neural Networks play a major role in our method," says Marr. "Our algorithm classifies light microscopic images and videos of individual cells by comparing these data with past experience from the development of such cells. In this way, the algorithm 'learns' how certain cells behave."

Three generations earlier than standard methods

Specifically, the researchers examined hematopoietic stem cells that were filmed under the microscope in the lab of Timm Schroeder at ETH Zurich.* Using the information on appearance and speed, the software was able to 'memorize' the corresponding behavior patterns and then make its prediction.

Hematopoietic Stem Cells, the New Target for Myeloproliferative Disorders
A new therapeutic target for certain kinds of myeloproliferative disease has been discovered by the Stem Cell Physiopathology group at the CNIC.

"Compared to conventional methods, such as fluorescent antibodies against certain surface proteins, we know how the cells will decide three cell generations earlier," reports ICB scientist Dr. Felix Buggenthin, joint first author of the study together with Dr. Florian Büttner.

But what is the benefit of this look into the future? As study leader Marr explains, "Since we now know which cells will develop in which way, we can isolate them earlier than before and examine how they differ at a molecular level. We want to use this information to understand how the choices are made for particular developmental traits."

New Method of Converting IPSCs into Hematopoietic Stem Cells for Disease Modeling Identified
Researchers have identified a new way through which induced pluripotent stem cells (iPSCs) can be converted into hematopoietic stem cells.

In the future, the focus will expand beyond hematopoietic stem cells. "We are using Deep Learning for very different problems with sufficiently large data records," explains Prof. Dr. Fabian Theis, ICB director and holder of the Mathematical Modelling of Biological Systems Chair at the TUM, who led the study together with Carsten Marr. "For example, we use very similar algorithms to analyze disease-associated patterns in the genome and identify biomarkers in clinical cell screens."

Source-Eurekalert

New Process of Developing Patient-Specific Hematopoietic Stem Cells Identified
The need for transplantable stem cells is great for patients suffering from blood diseases such as leukemia, lymphomas, multiple myeloma and immune deficiency.